Thymic Neoplasms and Treatment Outcomes in Veterinary Medicine

Thymic neoplasms, comprising thymomas and thymic carcinomas, represent uncommon mediastinal tumours in companion and large animal species. Clinical signs often reflect space-occupying effects—such as dyspnoea, cough and exercise intolerance—or paraneoplastic syndromes including myasthenia gravis and hypercalcaemia. Diagnosis typically relies on thoracic imaging (radiography and computed tomography), cytological sampling or core biopsy, sometimes complemented by immunohistochemistry. Surgical excision remains the cornerstone of treatment, offering prolonged survival when complete resection is achievable. Adjuvant radiation therapy, including intensity-modulated techniques, and chemotherapy may be instituted following incomplete resection or for aggressive histological subtypes. Prognostic determinants encompass tumour stage—commonly assessed by Masaoka-Koga criteria—histological classification and the presence of concurrent paraneoplastic disorders. Reported median survival times extend beyond two years in dogs and cats with early-stage disease, underscoring the potential for favourable long-term outcomes. Nevertheless, local recurrence, metastatic spread and late paraneoplastic manifestations warrant ongoing surveillance to optimise patient welfare and clinical decision-making.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Thymic Neoplasms and Treatment Outcomes in Veterinary Medicine publication trend

The graph below shows the total number of articles in thymic neoplasms and treatment outcomes in veterinary medicine across all publications each year (not limited to Nature Index journals).

Technical terms

Thymoma: A generally indolent epithelial tumour of the thymus, often encapsulated and prone to local compression rather than metastasis.

Thymic carcinoma: A malignant epithelial thymic neoplasm characterised by invasive growth, higher metastatic potential and poorer prognosis.

Paraneoplastic syndrome: Systemic clinical manifestations caused by tumour-derived factors, such as myasthenia gravis or hypercalcaemia, rather than direct tumour invasion.

Myasthenia gravis: An autoimmune disorder targeting neuromuscular junctions, frequently associated with thymic tumours and resulting in muscle weakness.

Masaoka-Koga stage: A staging system for thymic neoplasms based on tumour invasion, capsular integrity and dissemination, guiding prognosis and treatment planning.

Intensity-modulated radiation therapy (IMRT): A precise radiotherapy technique that allows conformal dose delivery to complex tumour shapes while sparing adjacent normal tissues.

References

1. Canine Epithelial Thymic Tumors: Outcome in 28 Dogs Treated by Surgery. Animals (2021).
2. The Outcome and CT Findings of Low-Dose Intensity Modulated Radiation Therapy with SQAP in a Cat with Thymoma. Veterinary Sciences (2020).
3. Prognostic factors and outcome in cats with thymic epithelial tumours: 64 cases (1999‐2021). Journal of Small Animal Practice (2023).